Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis.
Silva-Fernández L, Lunt M, Kearsley-Fleet L, Watson KD, Dixon WG, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium. Silva-Fernández L, et al. Among authors: hyrich kl. Rheumatology (Oxford). 2016 Nov;55(11):2033-2039. doi: 10.1093/rheumatology/kew314. Epub 2016 Aug 22. Rheumatology (Oxford). 2016. PMID: 27550304 Free PMC article.
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL, Symmons DP, Watson KD, Silman AJ; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Arthritis Rheum. 2006 Jun;54(6):1786-94. doi: 10.1002/art.21830. Arthritis Rheum. 2006. PMID: 16736520 Free article.
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: hyrich kl. Arthritis Rheum. 2006 Aug;54(8):2368-76. doi: 10.1002/art.21978. Arthritis Rheum. 2006. PMID: 16868999 Free article.
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: hyrich kl. Arthritis Rheum. 2007 Sep;56(9):2905-12. doi: 10.1002/art.22809. Arthritis Rheum. 2007. PMID: 17763428 Free PMC article.
298 results